Alnylam Pharmaceuticals
ALNY
#524
Rank
NZ$77.18 B
Marketcap
NZ$584.23
Share price
3.74%
Change (1 day)
19.74%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company